DIAGNOSTIC AND PROGNOSTIC SIGNIFICANCE OF STROMAL MYOFIBROBLASTS IN LARYNGEAL CARCINOGENESIS
Abstract
Background. Recent studies have shown that stromal reaction in cancer has a more important diagnostic and prognostic significance than previously thought. CD34-positive stromal cells and myofibroblasts may play an important role in host response to invasive cancer. The aim of our studies was therefore to analyze the distribution and immunohistochemical phenotype of stromal cells in epithelial hyperplastic lesions (EHL) and squamous carcinoma (SC) of the larynx, and to establish their diagnostic and prognostic significance.
Methods. We investigated samples of 62 resected larynxes with SC, 50 laryngeal biopsies of EHL and SC, and 5 samples of normal laryngeal mucosa. Immunohistochemistry was performed using antibodies against vimentin, a-smooth muscle actin (SMA), desmin, CD34 and leucocyte common antigen (LCA).
Results. The stroma of normal laryngeal mucosa and EHL contained scattered CD34-positive cells, but there were no SMApositive myofibroblasts. In contrast, the stroma of SC contained SMA-positive cells but there were no CD34-positive stromal cells. We observed two patterns of stromal reaction in SC: one was characterised by a marked proliferation of myofibroblasts and desmoplasia, with scarce lymphocytic infiltration; this pattern tended to be associated with well or moderately differentiated SC. The other was characterised by few myofibroblasts, weak desmoplasia, and dense lymphocytic infiltration; the latter pattern tended to be associated with moderately or poorly differentiated SC.
Conclusions. Our studies show that disappearance of CD34positive cells and appearance of SMA-positive myofibroblasts in the stroma is associated with transformation of laryngeal EHL to SC. This pattern of stromal reaction should be regarded as an additional marker of invasion. Our results also suggest that characteristics of stromal reaction in SC could be of prognostic significance.
Downloads
References
Dvorak HF. Tumors: wounds that do not heal. N Engl J Med 1986; 315: 1650–9.
Liotta LA, Rao CN, Barsky SH. Tumor invasion and the extracellular matrix. Lab Invest 1983; 49: 636–49.
Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature 2001; 411: 375–9.
Iozzo VR. Tumor stroma as a regulator of neoplastic behaviour. Lab Invest 1995; 73: 157–60.
Cintorino M, Bellizzi de Marco E et al. Expression of a-smooth-muscle actin in stromal cells of the uterine cervix during epithelial neoplastic changes. Int J Cancer 1991; 47: 843–6.
Zidar N, Gale N, Kambič V, Fischinger J. Proliferation of myofibroblasts in the stroma of epithelial hyperplastic lesions and squamous carcinoma of the larynx. Oncology 2002; 62: 381–5.
Kojc N, Zidar N, Gale N, Vodopivec B. CD34 and a-smooth muscle actin expression in stromal cells in epithelial hyperplastic lesions and squamous carcinoma of the larynx. In: Book of abstracts of 17th International meeting of Adriatic society of pathology. Zagreb: Department of gynaeocologic and perinatal pathology, 2002: 33–4.
Sappino AP, Skalli O, Jackson B, Schürch W, Gabbiani G. Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues. Int J Cancer 1988; 41: 707–12.
Schürch W, Seemayer T, Lagacé R. Stromal myofibroblasts in primary invasive and metastatic carcinoma. Virchows Arch 1981; 391: 125–39.
Schürch W, Seemayer T, Gabbiani G. The myofibroblast. A quarter century after its discovery. Am J Surg Pathol 1998; 22: 141–7.
Gabbiani G. The cellular derivation and the life span of the myofibroblast. Path Res Pract 1996; 192: 708–11.
Ohtani H. Stromal reaction in cancer tissue: Pathophysiologic significance of the expression of matrix-degrading enzymes in relation to matrix turnover and immune/ inflammatory reactions. Pathol Int 1998; 48: 1–9.
Frazier KS, Grotendorst GR. Expression of connective tissue growth factor mRNA in the fibrous stroma of mammary tumors. Int J Biochem Cell Biol 1997; 29: 153–61.
Seemayer TA, Schürch W, Lagacé R, Tremblay G. Myofibroblasts in the stroma of the invasive and metastatic carcinoma. Am J Surg Pathol 1979; 3: 525–33.
Barsky SH, Gopalakrishna R. Increased invasion and spontaneous metastasis of BL6 melanoma with inhibition of the desmoplastic response in C57 BL/6 mice. Cancer Res 1987; 47: 1663–7.
Nakanishi H, Oguri K, Takenaga K, Hosoda S, Okayama M. Differential fibrotic stromal response of host tissue to low- and high-metastatic cloned Lewis lung carcinoma cells. Lab Invest 1994; 70: 324–32.
Zidar N, Gale N, Kambič V, Fischinger J. Expression of tenascin and fibronectin in benign epithelial hyperplastic lesions and squamous carcinoma of the larynx. Anticancer Res 2001; 21: 451–4
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
